The Direct Cost of Rheumatoid Arthritis

Jul 1, 2000, 00:00
10.1046/j.1524-4733.2000.34001.x
https://www.valueinhealthjournal.com/article/S1098-3015(11)70001-8/fulltext
Title : The Direct Cost of Rheumatoid Arthritis
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)70001-8&doi=10.1046/j.1524-4733.2000.34001.x
First page :
Section Title :
Open access? : No
Section Order : 1

Objectives

This analysis estimated the direct cost of rheumatoid arthritis (RA) from a societal perspective.

Methods

Primary and secondary data sets were used to determine the rate of medical resource utilization. National average Medicare or Medicaid reimbursement rates were used to value direct costs (in 1994 dollars).

Results

Persons with RA have, on average, $1702 in direct costs for treating RA annually. More than half of the total cost is for medications. Nursing home care accounts for nearly one fifth of the cost and hospitalizations and ambulatory care (combined) comprise another fifth of the total cost. Travel to medical appointments and medical supplies make up the remaining 10%. The projected annual US direct costs are $3.6 billion for treating RA.

Conclusion

The health care utilization in persons with RA is frequent and includes a number of components leading to high annual direct cost.

Categories :
  • Cost/Cost of Illness/Resource Use Studies
  • Cost-comparison, Effectiveness, Utility, Benefit Analysis
  • Economic Evaluation
  • Epidemiology & Public Health
  • Multiple Diseases /No Specific Disease
  • Musculoskeletal Disorders
  • Public Health
  • Retrospective Databases: Electronic Medical and Health Records, Admin Claims
  • Specific Diseases & Conditions
  • Study Approaches
  • Systemic Disorders/Conditions
Tags :
  • cost of illness
  • direct cost
  • medical resource utilization
  • rheumatoid arthritis
Regions :
  • North America
ViH Article Tags :